BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36530047)

  • 1. Exploiting lactic acid bacteria for colorectal cancer: a recent update.
    Chen Y; Yang B; Zhao J; Ross RP; Stanton C; Zhang H; Chen W
    Crit Rev Food Sci Nutr; 2024; 64(16):5433-5449. PubMed ID: 36530047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of lactic acid bacteria in protection against colorectal cancer.
    Zhong L; Zhang X; Covasa M
    World J Gastroenterol; 2014 Jun; 20(24):7878-86. PubMed ID: 24976724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics intervention in colorectal cancer: From traditional approaches to novel strategies.
    Ha S; Zhang X; Yu J
    Chin Med J (Engl); 2024 Jan; 137(1):8-20. PubMed ID: 38031348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?
    Azcárate-Peril MA; Sikes M; Bruno-Bárcena JM
    Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G401-24. PubMed ID: 21700901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intervention on gut microbiota may change the strategy for management of colorectal cancer.
    Taghinezhad-S S; Mohseni AH; Fu X
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1508-1517. PubMed ID: 33295040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the treatment of colorectal cancer caused by gut microbiota.
    de Souza JB; Brelaz-de-Castro MCA; Cavalcanti IMF
    Life Sci; 2022 Feb; 290():120202. PubMed ID: 34896161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbe-based therapies for colorectal cancer: Advantages and limitations.
    Saeed M; Shoaib A; Kandimalla R; Javed S; Almatroudi A; Gupta R; Aqil F
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):652-665. PubMed ID: 34020027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
    Wong SH; Yu J
    Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Protective Role of Probiotics against Colorectal Cancer.
    Ding S; Hu C; Fang J; Liu G
    Oxid Med Cell Longev; 2020; 2020():8884583. PubMed ID: 33488940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Probiotics in Modulating Human Gut Microbiota Populations and Activities in Patients with Colorectal Cancer-A Systematic Review of Clinical Trials.
    Wierzbicka A; Mańkowska-Wierzbicka D; Mardas M; Stelmach-Mardas M
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33915854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal microbiota and colorectal cancer: a new aspect of research.
    Koliarakis I; Psaroulaki A; Nikolouzakis TK; Kokkinakis M; Sgantzos MN; Goulielmos G; Androutsopoulos VP; Tsatsakis A; Tsiaoussis J
    J BUON; 2018; 23(5):1216-1234. PubMed ID: 30512251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbe-based management for colorectal cancer.
    Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
    Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study Insights into Gastrointestinal Cancer through the Gut Microbiota.
    Kong F; Cai Y
    Biomed Res Int; 2019; 2019():8721503. PubMed ID: 31341907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics supplementation in patients with colorectal cancer: a systematic review of randomized controlled trials.
    Dikeocha IJ; Al-Kabsi AM; Eid EEM; Hussin S; Alshawsh MA
    Nutr Rev; 2021 Dec; 80(1):22-49. PubMed ID: 34027974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of the Use of Native and Engineered Probiotics for Colorectal Cancer Therapy.
    Han H; Zhang Y; Tang H; Zhou T; Khan A
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa.
    Lawrence GW; Begley M; Cotter PD; Guinane CM
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy.
    Kvakova M; Kamlarova A; Stofilova J; Benetinova V; Bertkova I
    World J Gastroenterol; 2022 Jul; 28(27):3370-3382. PubMed ID: 36158273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome in tumorigenesis and therapy of colorectal cancer.
    Wang L; Yu KC; Hou YQ; Guo M; Yao F; Chen ZX
    J Cell Physiol; 2023 Jan; 238(1):94-108. PubMed ID: 36409765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The food-gut axis: lactic acid bacteria and their link to food, the gut microbiome and human health.
    De Filippis F; Pasolli E; Ercolini D
    FEMS Microbiol Rev; 2020 Jul; 44(4):454-489. PubMed ID: 32556166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.